MarketScreener Editorial Features Endonovo Therapeutics Inc OTC Bulletin Board
Equities
US4111551044
End-of-day quote
Other stock markets
|
||
- USD | - |
2023 | Endonovo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
2023 | Endonovo Therapeutics, Inc 's Sofpulse® Secures Taiwan FDA Approval | CI |
- Stock Market
- Equities
- ENDV Stock
- Stock
- News Endonovo Therapeutics Inc
- MarketScreener Editorial Features